42204-02-4Relevant articles and documents
Binuclear dioxomolybdenum(VI) complexes of some tridentate ONS donor ligand containing [MoO2]2+ as the acceptor center: Synthesis, crystal structure, supramolecular architectures via hydrogen bonds, π-π Stacking and DFT calculations
Pramanik, Nikhil Ranjan,Chakraborty, Manashi,Biswal, Debanjana,Mandal, Sudhanshu Sekhar,Ghosh, Saktiprosad,Chakrabarti, Syamal,Sheldrick, William S.,Drew, Michael G.B.,Mondal, Tapan Kumar,Sarkar, Deblina
, p. 196 - 207 (2015)
A series of linear diimine and diamine-bridged binuclear dioxomolybdenum(VI) complexes having general formula [(MoO2L)2(B-B)] [where, B-B is a bridging linear N,N′-bidentate spacer 4,4′ bipyridine, 1,2 bis (4-pyridyl) ethene and 1,2
New pillared dioxomolybdenum(VI) complexes with ONS donor ligands and 4,4′-azopyridine spacer: 3D metal-organic supramolecular architectures and DFT calculations
Biswal, Debanjana,Pramanik, Nikhil Ranjan,Chakrabarti, Syamal,Drew, Michael G.B.
, p. 92 - 101 (2016)
Two new pillared binuclear dioxomolybdenum(VI) complexes [(MoO2L1)2(4,4′-azpy)] (1) and [(MoO2L2)2(4,4′-azpy)] (2) have been synthesized by the reaction of MoO2(acac)2
Methyl-2-arylidene hydrazinecarbodithioates: Synthesis and biological activity
Mahapatra, Manojkumar,Kulandaivelu, Umasankar,Saiko, Philipp,Graser, Geraldine,Szekeres, Thomas,Andrei, Graciela,Snoeck, Robert,Balzarini, Jan,Jayaprakash, Venkatesan
, p. 650 - 656 (2013/07/26)
Methyl-2-arylidene hydrazine-carbodithioate has not been of particular interest to researchers even though its metal complexes are extensively reported on due to their biological activity. This study examined the cytostatic and antiviral activity of twelve methyl-2-arylidene hydrazinecarbodithioates reported by many researchers as intermediates for the synthesis of thiosemicarbazides and the preparation of their metal complexes. Compounds IIc, IIi, and IIl with tridentate ligand features were found to have the lowest IC50 value (6.5 μM, ≈ 1 μM, and 0.8 μM, respectively) against HL60 human promyelocytic leukemia cells. They were also most inhibitory to human embryonic lung (HEL) fibroblast proliferation (5.3 μM, 17 μM, and 2.6 μM). Compound IIc and IIl show antiviral activity against wild-type herpes simplex virus (HSV), varicella zoster virus (VZV), and acyclovirresistant HSV; however, these activities were observed at concentrations at which the compounds also markedly inhibit HL60 and HEL cell proliferation.
Synthesis and characterization of oxothiomolybdenum(VI) complexes of some ONS chelating ligands by in situ oxo removal and sulphido insertion in the corresponding dioxomolybdenum(VI) complexes
Pramanik, Nikhil Ranjan,Ghosh, Saktiprosad,Raychaudhuri, Tapas Kumar,Mandal, Sudhanshu Sekhar
experimental part, p. 564 - 569 (2010/06/19)
This work reports the synthesis, characterization and electrochemical studies of several [MoVIOS]2+ complexes of some tridentate ONS donor ligands obtained by the condensation of salicylaldehyde/2- hydroxyacetophenone with S-benzyl and S-methyl dithiocarbazates. In this work PPh3 and PPh3S mixture is used as the synthetic reagent. The general strategy of synthesizing the complexes of the [MoOSL] type with the [MoOS]2+ core from corresponding complexes with the [MoO 2]2+ core by in situ oxoremoval-sulphide addition process. Presence of the oxothio core in all the [MoOSL] complexes is established by their reaction with KCN resulting in the formation of the CNS- species. All the complexes are characterized by various spectroscopic (NMR, IR, UV-Vis) techniques and also by cyclic voltammetry. All the complexes exhibit an irreversible overall 2 electron reductive response probably by proton assisted loss of the sulphide group leading to the formation of the corresponding [MoOL] complex.
